Literature DB >> 22305295

Impact of tissue volume and purification on clinical autologous islet transplantation for the treatment of chronic pancreatitis.

Shinichi Matsumoto1, Morihito Takita, Masayuki Shimoda, Koji Sugimoto, Takeshi Itoh, Daisuke Chujo, Jeffery A SoRelle, Yoshiko Tamura, Ana M Rahman, Nicholas Onaca, Bashoo Naziruddin, Marlon F Levy.   

Abstract

Autologous islet transplantation after total pancreatectomy is an excellent treatment for painful chronic pancreatitis. Traditionally, islets have been isolated without purification; however, purification is applied when the tissue volume is large. Nevertheless, the impact of tissue volume and islet purification on clinical outcomes of autologous islet transplantation has not been well examined. We analyzed 27 cases of autologous islet transplantation performed from October 2006 to January 2011. After examining the relationship between tissue volume and portal pressure at various time points, we compared islet characteristics and clinical outcomes between cases with complications (complication group) and without (noncomplication group), as well as cases with purification (purification group) and without (nonpurification group). Tissue volume significantly correlated with maximum (R = 0.61), final (R = 0.53), and delta (i.e., difference between base and maximum; R = 0.71) portal pressure. The complication group had a significantly higher body mass index, tissue volume, islet yield, and portal pressure (maximum, final, delta), suggesting that complications were associated with high tissue volume and high portal pressure. Only one of four patients (25%) in the complication group became insulin free, whereas 11 of 23 patients (49%) in the noncomplication group became insulin free with smaller islet yields. The purification group had a higher islet yield and insulin independence rate but had similar final tissue volume, portal pressure, and complication rates compared with the nonpurification group. In conclusion, high tissue volume was associated with high portal pressure and complications in autologous islet transplantation. Islet purification effectively reduced tissue volume and had no negative impact on islet characteristics. Therefore, islet purification can reduce the risk of complications and may improve clinical outcome for autologous islet transplantation when tissue volume is large.

Entities:  

Mesh:

Year:  2012        PMID: 22305295      PMCID: PMC4070319          DOI: 10.3727/096368911X623899

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  20 in total

1.  Islet cell transplantation for Type 1 diabetes.

Authors:  Shinichi Matsumoto
Journal:  J Diabetes       Date:  2009-08-17       Impact factor: 4.006

2.  Factors associated with insulin and narcotic independence after islet autotransplantation in patients with severe chronic pancreatitis.

Authors:  Syed A Ahmad; Andrew M Lowy; Curtis J Wray; David D'Alessio; Kywran A Choe; Laura E James; Andreas Gelrud; Jeffrey B Matthews; Horacio L R Rilo
Journal:  J Am Coll Surg       Date:  2005-09-23       Impact factor: 6.113

3.  Variables associated with islet yield in autologous islet cell transplantation for chronic pancreatitis.

Authors:  Morihito Takita; Bashoo Naziruddin; Shinichi Matsumoto; Hirofumi Noguchi; Masayuki Shimoda; Daisuke Chujo; Takeshi Itoh; Koji Sugimoto; Nicholas Onaca; Jeffrey P Lamont; Luis F Lara; Marlon F Levy
Journal:  Proc (Bayl Univ Med Cent)       Date:  2010-04

4.  Prediction of pancreatic tissue densities by an analytical test gradient system before purification maximizes human islet recovery for islet autotransplantation/allotransplantation.

Authors:  Takayuki Anazawa; Shuichiro Matsumoto; Yukihide Yonekawa; Gopalakrishnan Loganathan; Joshua J Wilhelm; Sajjad M Soltani; Klearchos K Papas; David E R Sutherland; Bernhard J Hering; A N Balamurugan
Journal:  Transplantation       Date:  2011-03-15       Impact factor: 4.939

5.  The risks of total pancreatectomy and splenic islet autotransplantation.

Authors:  S A White; N J London; P R Johnson; J E Davies; C Pollard; H H Contractor; D P Hughes; G S Robertson; P P Musto; A R Dennison
Journal:  Cell Transplant       Date:  2000 Jan-Feb       Impact factor: 4.064

6.  Effect of the two-layer (University of Wisconsin solution-perfluorochemical plus O2) method of pancreas preservation on human islet isolation, as assessed by the Edmonton Isolation Protocol.

Authors:  Shinichi Matsumoto; Sabrina A Qualley; Shilpa Goel; Derek K Hagman; Ian R Sweet; Vincent Poitout; D Michael Strong; R Paul Robertson; Jo Anna Reems
Journal:  Transplantation       Date:  2002-11-27       Impact factor: 4.939

7.  Body mass index reflects islet isolation outcome in islet autotransplantation for patients with chronic pancreatitis.

Authors:  Morihito Takita; Bashoo Naziruddin; Shinichi Matsumoto; Hirofumi Noguchi; Masayuki Shimoda; Daisuke Chujo; Takeshi Itoh; Koji Sugimoto; Yoshiko Tamura; Greg S Olsen; Nicholas Onaca; Jeffrey Lamont; Luis F Lara; Marlon F Levy
Journal:  Cell Transplant       Date:  2010-08-17       Impact factor: 4.064

8.  Autotransplantation of dispersed pancreatic islet tissue combined with total or near-total pancreatectomy for treatment of chronic pancreatitis.

Authors:  A C Farney; J S Najarian; R E Nakhleh; G Lloveras; M J Field; P F Gores; D E Sutherland
Journal:  Surgery       Date:  1991-08       Impact factor: 3.982

9.  Islet autotransplant outcomes after total pancreatectomy: a contrast to islet allograft outcomes.

Authors:  David E R Sutherland; Angelika C Gruessner; Annelisa M Carlson; Juan J Blondet; A N Balamurugan; Katie F Reigstad; Gregory J Beilman; Melena D Bellin; Bernhard J Hering
Journal:  Transplantation       Date:  2008-12-27       Impact factor: 4.939

10.  Iodixanol-controlled density gradient during islet purification improves recovery rate in human islet isolation.

Authors:  Hirofumi Noguchi; Tetsuya Ikemoto; Bashoo Naziruddin; Andrew Jackson; Masayuki Shimoda; Yasutaka Fujita; Daisuke Chujo; Morihito Takita; Naoya Kobayashi; Nicholas Onaca; Marlon F Levy; Shinichi Matsumoto
Journal:  Transplantation       Date:  2009-06-15       Impact factor: 4.939

View more
  8 in total

1.  No islets left behind: islet autotransplantation for surgery-induced diabetes.

Authors:  Melena D Bellin; A N Balamurugan; Timothy L Pruett; David E R Sutherland
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

2.  Effect of the Duration of Chronic Pancreatitis on Pancreas Islet Yield and Metabolic Outcome Following Islet Autotransplantation.

Authors:  Morihito Takita; Luis F Lara; Bashoo Naziruddin; Rauf Shahbazov; Michael C Lawrence; Peter T Kim; Nicholas Onaca; James S Burdick; Marlon F Levy
Journal:  J Gastrointest Surg       Date:  2015-05-02       Impact factor: 3.452

Review 3.  Islet autotransplantation and total pancreatectomy.

Authors:  Piotr Witkowski; Omid Savari; Jeffrey B Matthews
Journal:  Adv Surg       Date:  2014

Review 4.  Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions.

Authors:  Michael R Rickels; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

5.  Proposed thresholds for pancreatic tissue volume for safe intraportal islet autotransplantation after total pancreatectomy.

Authors:  J J Wilhelm; M D Bellin; T B Dunn; A N Balamurugan; T L Pruett; D M Radosevich; S Chinnakotla; S J Schwarzenberg; M L Freeman; B J Hering; D E R Sutherland; G J Beilman
Journal:  Am J Transplant       Date:  2013-10-21       Impact factor: 8.086

6.  Omental Pouch Technique for Combined Site Islet Autotransplantation Following Total Pancreatectomy.

Authors:  Mark J Stice; Ty B Dunn; Melena D Bellin; Mariya E Skube; Greg J Beilman
Journal:  Cell Transplant       Date:  2018-09-14       Impact factor: 4.064

7.  Mesenchymal Stem Cells from Chronic Pancreatitis Patients Show Comparable Potency Compared to Cells from Healthy Donors.

Authors:  Jingjing Wang; Yong Zhang; Colleen Cloud; Tara Duke; Stefanie Owczarski; Shikhar Mehrotra; David B Adams; Katherine Morgan; Gary Gilkeson; Hongjun Wang
Journal:  Stem Cells Transl Med       Date:  2019-01-24       Impact factor: 6.940

8.  Autologous Mesenchymal Stem Cell and Islet Cotransplantation: Safety and Efficacy.

Authors:  Hongjun Wang; Charlie Strange; Paul J Nietert; Jingjing Wang; Taylor L Turnbull; Colleen Cloud; Stefanie Owczarski; Betsy Shuford; Tara Duke; Gary Gilkeson; Louis Luttrell; Kathie Hermayer; Jyotika Fernandes; David B Adams; Katherine A Morgan
Journal:  Stem Cells Transl Med       Date:  2017-11-21       Impact factor: 6.940

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.